We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Par, Ortho-McNeil Settle Ultracet Patent Spat

Law360 (July 19, 2007, 12:00 AM EDT) -- Generic drug maker Par Pharmaceuticals has admitted to infringing a patent covering the acute pain treatment Ultracet as part of a deal to resolve litigation brought by Johnson & Johnson subsidiary...
To view the full article, register now.